Kathryn E. Falberg
2013
In 2013, Kathryn E. Falberg earned a total compensation of $2.7M as Former Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $380,000 |
|---|---|
| Option Awards | $890,560 |
| Salary | $472,693 |
| Stock Awards | $946,080 |
| Other | $3,622 |
| Total | $2,692,955 |
Falberg received $946.1K in stock awards, accounting for 35% of the total pay in 2013.
Falberg also received $380K in non-equity incentive plan, $890.6K in option awards, $472.7K in salary and $3.6K in other compensation.
Rankings
In 2013, Kathryn E. Falberg's compensation ranked 2,874th out of 12,286 executives tracked by ExecPay. In other words, Falberg earned more than 76.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,874 out of 12,286 | 77th |
Division Manufacturing | 958 out of 4,612 | 79th |
Major group Chemicals And Allied Products | 252 out of 1,462 | 83rd |
Industry group Drugs | 170 out of 1,156 | 85th |
Industry Pharmaceutical Preparations | 140 out of 890 | 84th |
Source: SEC filing on June 10, 2015.
Falberg's colleagues
We found four more compensation records of executives who worked with Kathryn E. Falberg at Jazz Pharmaceuticals in 2013.